Pharma & Biotech

A landmark expansion of Monte Rosa Therapeutics' existing collaboration with pharmaceutical leader Novartis has ignited a dramatic surge in its...

The markets are presenting a puzzling contradiction with Dynavax Technologies Corporation. The biopharmaceutical company recently reported record-breaking financial results and...

In a notable strategic shift, Pfizer and its collaborator Arvinas have announced they will seek an external commercialization partner for...

Global alternative asset manager TPG is actively pursuing major acquisitions across multiple sectors, demonstrating its aggressive growth strategy. The firm...

Embecta, a specialized diabetes care company, is currently presenting investors with a puzzling dichotomy. Despite posting solid quarterly figures and...

Viking Therapeutics shares are experiencing a severe sell-off, extending recent losses with a further 1.64% decline over the past trading...

In a landmark transaction that concludes its 124-year history as a publicly traded company, Walgreens Boots Alliance has been formally...

Deciphera Pharmaceuticals has achieved a pivotal regulatory victory with the European Commission granting marketing authorization for its drug ROMVIMZA™. The...

A routine tax-related transaction by a senior executive created downward pressure on Apellis Pharmaceuticals shares this week. Despite the stock...

The biotechnology landscape witnessed a significant consolidation in the second quarter of 2024 as Vertex Pharmaceuticals Incorporated finalized its acquisition...